SEC demonstrated significantly longer time to flare vs PBO w/ sustained improvement of ERA and JPsA signs and symptoms up to Wk 104. No new safety signals. Plenary Abs 1424 #ACR21 #RheumNow @RheumNow https://t.co/VF2HmJ3Ha9 https://t.co/ApYFusADHX
Links:
Secukinumab Treatment in Children and Adolescents with Enthesitis-related Arthr…
http://ow.ly/dbfH50GtUhX
08-11-2021